Skip to main content
SpringerLink
Log in

Gegen Pseudomonas aeruginosa hilft Colistin-Inhalation

  • AKTUELLE MEDIZIN_KRITISCH GELESEN
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Mehr als 20% der Patienten mit Bronchiektasen entwickeln eine chronischen Pseudomonas-aeruginosa-Infektion. Inhalativ appliziertes Colistin ist eine beliebte Therapieoption — laut einer Studie zurecht.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  • Haworth CH et al. Inhaled colistin in patients with bronchiektasis and chronic pseudomonas aeruginosa infection. Am J Respir Crit Care Med 2014;189:976–982

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    D. Reinhardt

Authors
  1. D. Reinhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reinhardt, D. Gegen Pseudomonas aeruginosa hilft Colistin-Inhalation. MMW - Fortschritte der Medizin 156, 40 (2014). https://doi.org/10.1007/s15006-014-3725-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-014-3725-z

Search

Navigation